Wellstone Retains Key Tobacco Chemist DURHAM, N.C., Nov. 29 /PRNewswire-FirstCall/ -- Wellstone Filters (OTC:WLSF) (BULLETIN BOARD: WLSF) announced today that it has retained Dr. John H. Lauterbach, Ph.D., DABT, FAIC, FRSC, Certified Toxicologist, Certified Professional Chemist, Chartered Scientist and Chartered Chemist as a consultant and Wellstone's Chief Scientific Advisor. Wellstone believes that the addition of Dr. Lauterbach will assist Wellstone to further develop its formulation, to communicating its technology to other manufacturers and will be essential in negotiating on Wellstone's behalf. Dr. Lauterbach recently retired after twenty-four years with the Research & Development Department at Brown & Williamson Tobacco Corporation. During his tenure at B&W, Dr. Lauterbach served as Principal Scientist in Scientific & Regulator Affairs and Director, Research Services. From 1993 to 1998, he also served as Chairman of the Board of the Tobacco Institute Testing Laboratory and Chairman of the US Technical Advisory Committee to ISO Technical Committee TC126 on Tobacco and Tobacco Products. Dr. Lauterbach is a frequent presenter at the annual Tobacco Science Research Conferences and is author or co-author on numerous presentations and journal articles on tobacco science and toxicology. Wellstone believes that its patented filter formulation removes tars and certain carcinogens, while providing better taste. However, any claim as to the benefit of any Wellstone cigarettes to be sold will be made within the parameters prescribed by the Federal Trade Commission. Wellstone emphasizes that NO cigarette is safe. This corporate communication by Wellstone is not intended to induce any person to purchase future Wellstone tobacco products. ABOUT THE COMPANY Wellstone Filters, Inc. has developed and patented filter material that removes certain carcinogens and other toxins produced when tobacco is smoked -- without removing the compounds thought to be associated with the pleasurable effects of smoking. Wellstone seeks to promote material for cigarette filters that will enable major cigarette manufacturers to provide consumers with an equally enjoyable cigarette with substantially fewer carcinogens. For more information, please see http://www.wellstonefilters.com/ or call Investor relations at 303-620-9194. In addition, all current shareholders, and interested parties should sign into our private Corporate Guest Book, http://www.corporateguestbook.com/?WLSF to receive timely updates and information on any future developments as they happen. Note: Except for the historical information contained herein, this new release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third- party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by Wellstone with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of Wellstone as of the date of this release. Wellstone and its managers and agents undertake no obligation to publicly update any forward- looking statements. DATASOURCE: Wellstone Filters CONTACT: Wellstone Filters Investor relations, +1-303-620-9194 Web site: http://www.lowertar.com/ http://www.wellstonefilters.com/ http://www.corporateguestbook.com/

Copyright